系统性硬化症患者胃食管反流病的外科治疗
本研究比较了胃底折叠术与胃旁路术治疗系统性硬化症合并胃食管反流病(GERD)的围手术期及中期结局。腹腔镜Roux-en-Y胃旁路术安全,或可作为食管动力障碍患者的替代选择。
要点
- 系统性硬化症合并GERD患者常伴食管动力障碍,抗反流手术需个体化。
- 胃旁路术组随访症状改善率高于胃底折叠术组(5/5 vs 3/5)。
- 两种术式均无30天死亡,腹腔镜Roux-en-Y胃旁路术安全可行。
核心结论
- 腹腔镜Roux-en-Y胃旁路术作为抗反流手术是安全的,对于合并食管动力障碍的系统性硬化症GERD患者,可能提供胃底折叠术之外的替代选择。
研究设计与样本
- 胃底折叠术7例(2例Nissen、4例Toupet、1例Dor),Roux-en-Y胃旁路术7例。
主要发现
- 平均体重指数26 kg/m2,两组均无30天死亡。
- 胃底折叠术组中位随访97个月(范围28-204个月),胃旁路术组19个月(范围1-164个月)。
- 术前吞咽困难、烧心、反流分别占71%(n=10)、86%(n=12)、64%(n=9)。
- 11例术前行pH监测,其中91%存在异常酸暴露;术前上消化道内镜显示85%(n=11)有食管炎,2例Barrett食管。
- 所有胃旁路术患者和71%胃底折叠术患者存在食管动力障碍;随访时胃旁路术组5例均报告症状改善或消失,胃底折叠术组仅3例(50%)报告改善。
临床怎么用
- 对于系统性硬化症合并GERD及食管动力障碍的患者,可考虑腹腔镜Roux-en-Y胃旁路术作为抗反流术式。
- 术前应评估食管动力和酸暴露,以个体化选择术式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Systemic sclerosis (scleroderma) is frequently associated with both gastroesophageal reflux disease (GERD) and simultaneous esophageal dysmotility. Anti-reflux procedures in this patient population must account for the existing physiology of each patient and likely disease progression. We aim to compare perioperative and intermediate outcomes of fundoplication versus gastric bypass for the treatment of GERD. METHODS: After IRB approval, patients with systemic sclerosis undergoing fundoplication or gastric bypass for the treatment of GERD from 2004 to 2016 were identified. Demographics, perioperative data, immediate complications, and symptom improvement were retrieved and analyzed. RESULTS: Fourteen patients with systemic sclerosis underwent surgical treatment of GERD during the defined study period. Average body mass index was 26 kg/m2. Seven fundoplications (2 Nissens, 4 Toupets, and 1 Dor) and 7 Roux-en-Y gastric bypasses (RYGB) were performed. No 30-day mortality was observed in either group. Median follow-up was 97 months for the fundoplication group (range 28-204 months), and 19 months for the RYGB group (range 1-164 months). Preoperatively, dysphagia, heartburn, and regurgitation were present in 71% (n = 10), 86% (n = 12), and 64% (n = 9) of patients, respectively. Eleven patients had pH study prior to surgical intervention, and 91% of them had abnormal acid exposure. Esophagitis was evident in 85% (n = 11) of patients during preoperative upper endoscopy, and two patients had Barrett's esophagus. Impaired esophageal motility was present in all RYGB patients and 71% of fundoplication patients. Of the patients who had assessment of their GERD symptoms at follow-up, all five patients in the RYGB group and only 3 (50%) patients in the fundoplication group reported symptom improvement or resolution. CONCLUSIONS: Laparoscopic RYGB as an anti-reflux procedure is safe and may provide an alternative to fundoplication in the treatment of GERD for systemic sclerosis patients with esophageal dysmotility.
引用
- Yan J, Strong AT, Sharma G, et al. Surgical management of gastroesophageal reflux disease in patients with systemic sclerosis. Surg Endosc. 2018. PMID: 29435755. doi:10.1007/s00464-018-6115-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。